Birch Pollen Allergen Immunotherapy Reprograms Nasal Epithelial Transcriptome and Recovers Microbial Diversity

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2019.02.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Sublingual Allergen Immunotherapy With a Liquid Birch Pollen Product in Seasonal Allergic Rhinoconjunctivitis With/Without Asthma*

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Continuous Nasal Airflow Resistance During Birch Pollen Provocation Test

2013English

Glutathione-S-Transferase Is a Minor Allergen in Birch Pollen Because of Restricted Release From Hydrated Pollen Grains

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Ligand Recognition of the Major Birch Pollen Allergen Bet v 1 Is Isoform Dependent

PLoS ONE
Multidisciplinary
2015English

Allergen-Specific Immunotherapy

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2018English

Conversion of the Major Birch Pollen Allergen, Bet v 1, Into Two Nonanaphylactic T Cell Epitope-Containing Fragments: Candidates for a Novel Form of Specific Immunotherapy.

Journal of Clinical Investigation
Medicine
1997English

Nasal Challenge With Ragweed Pollen in Hay Fever Patients. Effect of Immunotherapy.

Journal of Clinical Investigation
Medicine
1985English

Birch Pollen Allergy in Europe

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Structural Study of Biologically Significant Ligands With Major Birch Pollen Allergen Betv1 by Docking and Molecular Dynamics Simulation

Bioinformation
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy